Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
81 Cards in this Set
- Front
- Back
Adverse effect |
A general term for any undesirable effects that are a direct response of one or more drugs |
|
Allergic reaction |
An immunologic hypersensitivity of a patient to a particular medication, a type of adverse drug effect |
|
Bioavailability |
A measure of the extent of drug absorption for a given drug and route from 0 to 100% |
|
Contraindication |
Any condition, especially one related to a disease state or patient characteristic, including current or recent drug therapy, which renders a particular form of treatment improper or undesirable |
|
Drug accumulation |
Occurs when the dosage in the body surpasses the amount that the body can get rid of through metabolism and excretion |
|
Drug interactions |
Alteration in the pharmacologic or pharmacokinetic activity of a given drug caused by the presence of one or more additional drugs; it is usually related to the effects on the enzymes required for metabolism of the involved drugs |
|
Efficacy |
How well a drug produces its effect |
|
Half life |
In pharmacokinetics, the time required for half of an administered dose of a drug to be eliminated by the body, or the time it takes for the blood level of a drug to be reduced by 50% |
|
Idiosyncratic response |
An abnormal or unexpected response to a medication, other than an allergic reaction, that is peculiar to an individual patient |
|
Pharmacokinetics |
The study of what happens to a drug from the time it is put into the body until the parent drug and all metabolites have left the body pharmacokinetics include the drug absorption, distribution, metabolism, and excretion |
|
Potency |
The amount of drug that must be given to produce a response |
|
Precautions |
Situation is one of the drug is given, it has to be used with very careful |
|
Steady state |
The physiologic state in which the amount of drugs removed via elimination is equal to the amount of drug absorbed with each dose |
|
Tolerance |
Reduced response to a drug after prolong do use |
|
Acetylcholine |
The neurotransmitter responsible for the transmission of nerve impulses to effector cells in the parasympathetic nervous system |
|
Adrenergic agonist |
Drugs that stimulate and mimic the actions of sympathetic nervous system neurotransmitters norepinephrine, epinephrine, and dopamine. Also called sympathomimetics. |
|
Alpha adrenergic receptor |
A class of adrenergic receptors that are further subdivided into alpha-1 and alpha-2 adrenergic receptors |
|
Agonist |
Drugs with a specific receptor affinity that mimic the body’s natural chemicals, like hormones and neurotransmitters |
|
Antagonist |
Drugs that bind to specific receptors and inhibit or block the response of the receptors |
|
Autonomic |
Involuntary or unconscious; autonomic nervous system does things like breathing or controlling heart rate without you having to thank |
|
Beta adrenergic receptor |
Receptors located on postsynaptic cells that are stimulated by specific autonomic nerve fibers. Beta-1 adrenergic receptors are located primarily in the heart where is beta-2 adrenergic receptors are located in the smooth muscle fibers of the bronchioles, arterioles, and visceral organs |
|
Cholinergic agonist |
Drugs that mimic the effects of acetylcholine and can stimulate cholinergic receptors, either directly or indirectly. Also called parasympathomimetic. |
|
Cholinergic antagonist |
Drugs that block the action of acetylcholine and substances similar to acetylcholine at receptor sites in the synapse |
|
Chronotropic effect |
Modifies the heart rate. Positive effect increases heart rate while negative effect decreases heart rate |
|
Dromotropic effect |
Affects the speed of conduction of cardiac electrical nerve impulses through the atrioventricular node. Positive effect increases speed while negative effect decreases speed |
|
Inotropic effect |
Modifies the force or speed of contraction of muscles. Positive effect increases force/speed while negative effect decreases |
|
Muscarinic receptors |
Cholinergic receptors located postsynaptically in the effector organs such as smooth muscle, cardiac muscles, and glands supplied by the parasympathetic nerve fibers |
|
Nicotinic receptors |
Cholinergic receptors located in the ganglia of both parasympathetic nervous system and the sympathetic nervous system |
|
Parasympatholytic |
Drugs that reduce the activity of the parasympathetic nervous system; also called anti-cholinergics |
|
Sympathomimetic |
Drugs that mimic the sympathetic nervous system, also referred to as adrenergic agonist drugs |
|
Vasoconstrict |
The narrowing or constriction of blood vessels by small muscles in their walls; increases blood pressure |
|
Vasodilate |
The widening of blood vessels usually near the surface of the skin, which leads to increased blood flow and decreased blood pressure |
|
What are the five parts of the nursing process? |
Assessment human needs statement planning with outcome identification implementation including patient education evaluation |
|
What are the nine rights of medication administration? |
Right drug Right dose Right time Right route and form Right patient Right documentation Right reason or Indication Right response Right to refuse |
|
What are the three types of drug names? |
Chemical, generic, and trade |
|
What lab values assess drug impact on the liver, kidney, and hematologic? |
Liver - AST, ALT Kidney - Creatinine, creatinine clearance, BUN Hematologic - Hematocrit, hemoglobin, WBC’s, and platelets (CBC) |
|
What are the four steps of pharmacokinetics? |
Absorption Distribution Metabolism Excretion |
|
What can affect absorption rate? |
Route of administration, solubility and concentration of the drug, circulation to the area, surface conditions, contact time, PH at the absorption site, cell membrane transport mechanisms |
|
What does the distribution rate depend on? |
Blood flow (more blood flow = faster distribution), affinity to the body tissue, and protein binding affect |
|
What is protein binding? |
When a drug enters the circulatory system and is distributed all over the body, organs start to metabolize in excrete the drug through the liver and kidneys. Most of the drug is bound to a protein, like albumin, making it pharmacologically inactive, while a limited portion of the drug stays unbound and pharmacologically active. This is because when the drug is bound to a protein, it is usually too large to fit through the walls of blood capillaries in into the surrounding tissues. When a drug is unbound, it is small enough to fit through the walls of blood capillaries and go to the extra vascular tissue to get to the site of action |
|
Someone with low ______ _______ is at greater risk for toxicity from a highly protein bound drug |
Serum albumin |
|
What is the principle site of drug metabolism? |
The liver |
|
What is the primary route for excretion? |
The kidneys |
|
What is the first pass effect? |
Since the liver is the principal site of drug metabolism, any drug that gets absorbed by the intestine must first pass through the liver to get into blood circulation and become bioavailable. The liver chemically changes drugs into inactive metabolites. The more inactive metabolites that are formed, the less of the actual drug will become bioavailable. |
|
What is the cytochrome P-450 system? |
During hepatic metabolism, a large class of enzymes called the cytochrome P-450 enzymes are used to control several reactions that help with the metabolism of drugs. These enzymes specifically target lipid soluble drugs that are generally hard to eliminate from the body and are responsible for the metabolism of most drugs. And each specific P-450 enzyme has a corresponding drug substrate, making at one of the most important systems affecting drug-drug interactions. If two drugs are both metabolized by the same enzyme and are administered together, they may compete for the enzyme, which can cause the drugs to become more or less bioavailable than intended |
|
What do rising levels of creatinine indicate? |
Decreased kidney function |
|
What does BUN indicate? |
Hydration status |
|
What is the minimum amount of urine a patient should produce? |
At least 30 mL per hour |
|
How many half-lives does it take to reach a steady state? |
4 to 5 |
|
What is a loading dose? |
A larger dose than usual to get the drug into the system |
|
What is the difference between additive, synergistic, potentiated, and antagonistic effects? |
Additive - 2 similar drugs given together to create the sum of drugs effect (1+1=2) Synergistic - two unlike drugs given together to create an effect greater than either alone (1+1=3) Potentiated - two unlike drugs given together, but the effect of only one drug is enhanced (1+1/2=2) Antagonistic - two unlike drugs given together, but one drug blocks the effect of the other (1+1=0) |
|
What are the antidotes for the following drugs: acetaminophen, organophosphates, tricylic antidepressants, benzodiazepines, beta blockers, opiates, and calcium channel blockers |
Acetaminophen - acetylcysteine Organophosphates - atropine Tricyclic antidepressants - sodium bicarbonate Benzodiazepines - flumazenil Beta blockers - glucagon Opiates - naloxone Calcium channel blockers - calcium IV |
|
What is beers criteria? |
Helps prevent an adverse drug event in older adult patients. It provides a list of medications to either avoid or consider and use with extreme caution. |
|
What are the three pregnancy risk categories? |
Drug properties Fetal gestational age Maternal factors |
|
How are drugs categorized in relation to pregnancy? |
A through D and X with A showing no increased risk of fetal abnormalities and X showing positive evidence of fetal abnormalities |
|
How are controlled substances categorized? |
C-1 through C-5 C-1 are hard drugs, C-2 and 3 are narcotics, C-5 are anti-diarrheals |
|
Type of needle and syringe used for insulin, transdermal, subcutaneous, and intramuscular injections |
Insulin- insulin syringe with fixed needle Transdermal- 3/8” 26-31 gauge needle Subcutaneous- 3/8” to 1/2” to 5/8” 25-31 gauge needle Intramuscular- 1” to 3” 18-25 gauge needle |
|
Signs and symptoms of anaphylaxis |
Difficulty breathing, low blood pressure, increased heart rate, dilated pupils, diaphoresis, panic, respiratory arrest |
|
What are the differences between alpha-1 and alpha-2 receptors? |
Alpha-1: located on postsynaptic effector cells (tissue, muscle, or organ the nerve stimulates) and causes excitement/vasoconstriction Alpha-2: located on presynaptic nerve terminals and cause relaxation/inhibit SNS stimulation |
|
What are the differences between beta-1 and beta-2 receptors? |
Both located on postsynaptic effector cells Beta-1: located primarily in the heart and affect heart rate and contractility Beta-2: located in the smooth muscle fibers of bronchioles, arterioles, and visceral organs. Causes broncho/vasodilation |
|
What are the three functions of the autonomic nervous system? |
Regulate the heart Regulate secretory glands Regulate smooth muscle |
|
What are the three functions of the sympathetic nervous system and how does it maintain these functions? |
Regulates cardiovascular system •maintains blood flow to brain •redistributes blood with exercise •compensates for blood loss Regulates body temperature •dilates and constricts vessels •sweating •goosebumps Fight or flight reaction •increase HR and BP •dilates bronchi and pupils •mobilizes stored energy/regulates glucose •shunts blood from viscera to skeletal muscles |
|
What are the seven functions of the parasympathetic nervous system? |
Slows heart rate Increases gastric secretions Emptying of bladder and bowel Focus eye for near vision Constricts pupil Contracts bronchial smooth muscle |
|
What are the differences in how the SNS and PSNS effect the body? |
SNS (adrenergic, anti-cholinergic, sympathetic agonist) - dilates pupils/dry eyes, increased HR/contractility, decreased GI motility/secretions, dilates trachea/bronchi, constricts blood vessels, decreases salivation PSNS (Cholinergic agonist, anti-adrenergic) - constricts pupils/tears flow, decreased HR/contractility, increased GI motility/secretions, constrict trachea/bronchi, dilates blood vessels, increased salivation |
|
SLUDGE(S) reaction |
The effects of Cholinergic poisoning S - salivation L - lacrimation U - urination D - diarrhea G - GI cramps E - emesis S - slows HR |
|
SNS synonyms |
Fight or flight Adrenergic/adrenergic agonist Sympathomimetic |
|
What blocks the SNS |
Adrenergic antagonists Sympatholytic |
|
PSNS synonyms |
Rest and digest Cholinergic/Cholinergic agonist |
|
What blocks the PSNS |
Anti Cholinergic Cholinergic antagonist Parasympatholytic |
|
Epinephrine drug class, mechanism of action, indications, contraindications/precautions, and adverse effects |
Drug class - non selective adrenergic agonist MOA - stimulates alpha and beta receptors (positive ino/Chronotropic effects, increase BP) Indications - anaphylaxis, asthma, cardiac arrest (emergency drug for resuscitation) Contraindication/precautions - if a pt has chest pain/active MI, tachycardia, hypertension, glaucoma Adverse effects - HR and BP too high (sweating, dizziness, palpitations, nausea, vomiting) |
|
What do you need to check/monitor when giving epinephrine? |
Monitor HR and BP |
|
Norepinephrine and phenylephrine drug class, mechanism of action, and indications |
Drug class - alpha adrenergic agonists MOA - stimulate alpha receptors Indications - used for hypotension and shock to cause vasoconstriction (raises BP and HR) |
|
Tamulosin and phentolamine drug class, mechanism of action, and indications |
Drug class - alpha adrenergic receptor antagonists MOA - blocks alpha 1 receptors (blocks vasoconstriction/reduces peripheral vascular resistance) Indications - men with enlarged prostate (allows them to pee) (tamulosin) IV extravasion of a vasoconstricting drug (phentolamine) |
|
Metaprolol drug class, mechanism of action, indications, and contraindications |
Drug class - selective beta blocker MOA - mostly blocks beta-1 but can block beta-2 in high doses Indications - patients who have had a heart attack (lowers BP/HR) Contraindications - do not stop abruptly, do not give if pt has low HR (below 60 bpm) |
|
What do you never want to do when giving Metaprolol or propranolol? |
Never stop abruptly |
|
What should you assess when giving Metaprolol or propranolol? |
HR (no less than 60) and BP (no less than 100) |
|
Propranolol drug class, mechanism of action, indications, and contraindications |
Drug class - non selective beta blocker MOA - decreases HR/contractility, bronchoconstriction Indications - angina, dysrhythmias, hypertension, post-MI, migraines Contraindications - asthma |
|
Bethanchol drug class, indications, pharmacokinetics, and mechanism of action |
Drug class - Cholinergic agonist Indications - urinary retention not caused by an obstruction Pharmacokinetics - mainly oral MOA - increases muscle tone in bladder (contraction) and relaxes sphincters in bladder (helps to urinate) |
|
Pyridostigmine drug class, indications, pharmacokinetics, and adverse effects |
Drug class - indirect acting Cholinergic agonist Indications - myasthenia gravis to gain muscle strength Pharmacokinetics - mainly oral, can be IV Adverse effects - too much SLUGES effect |
|
What should you monitor when giving pyridostigmine and what is the antidote? |
Monitor first dose Atropine is the antidote |
|
Atropine drug class, indications, mechanism of action, contraindications, adverse effects, and what to consider |
Drug class - Cholinergic antagonist Indications - cardiac bradycardia (emergency drug) MOA - increases HR Contraindications - myasthenia gravis and glaucoma Adverse effects - dry mouth, blurred vision What to consider - oral hygiene, be careful when pt is sweating a lot |